Abstract
Get full access to this article
View all access options for this article.
References
1.Outbreaks chronology: Ebola virus disease . US Centers for Disease Control and Prevention website. Updated December 18 , 2014 . http://www.cdc.gov/vhf/ebola/outbreaks/history/chronology.html. Accessed December 18 , 2014
2.Biodefense and Emerging Infectious Diseases: NIAID emerging infectious diseases/pathogens . National Institute of Allergy and Infectious Diseases website. Updated August 8 , 2014 . http://www.niaid.nih.gov/topics/BiodefenseRelated/Biodefense/Pages/CatA.aspx. Accessed December 19 , 2014
3.
Boddie
C
,
Sell
TK
,
Watson
M
Federal funding for health security in FY2015 . Biosecur Bioterror , 2014 ; 12 (4 ):163 -177 .
4.Emerging viral pathogens section . National Institute of Allergy and Infectious Diseases website. Updated June 1 , 2011 . http://www.niaid.nih.gov/labsandresources/labs/aboutlabs/emergingviralpathogens/Pages/default.aspx. Accessed December 18 , 2014
5.
Pellerin
C.
DTRA medical countermeasures help West African Ebola crisis . DoD News December 12 , 2014 . http://www.defense.gov/news/newsarticle.aspx?id=123822. Accessed December 19 , 2014
6.
Pollack
A.
Trial of Ebola Vaccines' Effectiveness is Announced . New York Times January 23 , 2015 . http://www.nytimes.com/2015/01/23/business/international/trial-of-2-ebola-vaccines-effectiveness-is-announced.html?_r=0. Accessed January 29 , 2015
7.NIAID/GSK experimental Ebola vaccine appears safe, prompts immune response [news release] . November 28 , 2014 . National Institutes of Health . http://www.nih.gov/news/health/nov2014/niaid-28.htm. Accessed December 19 , 2014
8.
Jahrling
P.
Overview of lead experimental medical countermeasures for Ebola and product-specific considerations . Presentation at the JHSPH Ebola Crisis Dean's Symposium ; October 15, 2014 ; Baltimore, MD . http://www.jhsph.edu/events/2014/ebola-forum/ebola-forum-video-archive/deans-symposium-on-ebola-crisis-context-and-response-part-4. Accessed December 19 , 2014
9.Merck-New Link Ebola vaccine trial resumes at lower dose: Geneva hospital . Reuters January 5 , 2015 . http://www.reuters.com/article/2015/01/05/us-health-ebola-vaccine-idUSKBN0KE0XP20150105. Accessed January 29 , 2015
10.NIH begins early human clinical trial of VSV Ebola vaccine [news release] . October 22 , 2014 . National Institutes of Health . http://www.nih.gov/news/health/oct2014/niaid-22.htm. Accessed December 19 , 2014
11.Profectus BioSciences receives $9.5 million Department of Defense funding to manufacture trivalent VesiculoVax™-vectored vaccine to protect against all Ebola and Marburg viruses [news release] . October 31 , 2014 . Profectus BioSciences, Inc . http://www.profectusbiosciences.net/pdfs/releases/2014%201031%20Profectus%20DoD%20Tri-V%20Ebola%20Contract.pdf. Accessed December 19 , 2014
12.Profectus BioSciences receives $8.6 million HHS contract to accelerate Ebola vaccine into human clinical studies [news release] . October 22 , 2014 . Profectus BioSciences, Inc . http://www.profectusbiosciences.net/pdfs/releases/2014%201022%20Profectus%20Ebola%20HHS%20BARDA.pdf. Accessed December 19 , 2014
13.Bavarian Nordic announces first subject dosed with MVA-BN Filo in a Phase 1 study investigating a new prime-boost regimen of Ebola candidate vaccines [company announcement] . December 4 , 2014 . Bavarian Nordic . http://id.bavarian-nordic.com/media/news.aspx?news=4314. Accessed December 19 , 2014
14.Bavarian Nordic enters licensing and supply agreement with Janssen on MVA-BN Ebola vaccine . October 22 , 2014 . Bavarian Nordic . http://id.bavarian-nordic.com/media/news.aspx?news=4241. Accessed December 19 , 2014
15.
Akst
J.
Ebola update: researchers gear up for efficacy trials of experimental Ebola vaccines in Africa . Scientist January 12 , 2015 . http://www.the-scientist.com/?articles.view/articleNo/41882/title/Ebola-Update/. Accessed January 29 , 2015
16.
Barry
F.
Ebola: which are the leading vaccine candidates? . BioPharma January 27 , 2015 . http://www.biopharma-reporter.com/Bio-Developments/Ebola-which-are-the-leading-vaccine-candidates. Accessed January 29 , 2015
17.Novavax announces Ebola vaccine development program at the 8th Vaccine and ISV Conference in Philadelphia [news release] . October 27 , 2014 . Novavax . http://www.novavax.com/download/releases/Novavax%20Announces%20Ebola%20Vaccine%20Development%20Program%20at%20the%208th%20Vaccine%20and%20ISV%20Conference%20in%20Philadelphia.pdf. Accessed January 29 , 2015
18.Ebola Vaccine Landscape [PowerPoint presentation] . US Department of Health and Human Services . January 8 , 2015 . http://www.who.int/mediacentre/events/2015/S2.4_Robinson_ebola_MCM_landscape.pdf. Accessed January 29 , 2015
19.Ebola/Marburg: rabies vaccine protects nonhuman primates against deadly Ebola virus . National Institute of Allergy and Infectious Diseases website. Updated July 15 , 2013 . http://www.niaid.nih.gov/topics/ebolaMarburg/Pages/rabiesVaccebola.aspx. Accessed December 19 , 2014
20.Fact Sheet: update on the Ebola response . Official Wire website. December 2 , 2014 . http://www.officialwire.com/pr/fact-sheet-update-on-the-ebola-response/. Accessed December 19 , 2014
21.About investigational TKM-Ebola therapeutic . Tekmira website. http://www.tekmira.com/pipeline/tkm-ebola.php. Accessed December 19 , 2014
22.BioCryst announces study results for BCX4430 in a non-human primate model of Ebola virus infection [press release] . December 23 , 2014 . BioCryst . http://investor.shareholder.com/biocryst/releasedetail.cfm?ReleaseID=888802. Accessed January 29 , 2015
23.
Caulderwood
K.
Chimerix Ebola drug Brincidofovir begins testing in Liberia . International Business Times January 8 , 2015 . http://www.ibtimes.com/chimerix-ebola-drug-brincidofovir-begins-testing-liberia-1777636. Accessed January 29 , 2015
24.Experimental therapies: growing interest in the use of whole blood or plasma from recovered Ebola patients (convalescent therapies) [news release] . September 26 , 2014 . World Health Organization website. http://www.who.int/mediacentre/news/ebola/26-september-2014/en/. Accessed December 19 , 2014
25.
Kroll
D.
FDA moves on Tekmira's Ebola drug while Sarepta's sits unused . Forbes August 7 , 2014 . http://www.forbes.com/sites/davidkroll/2014/08/07/fda-moves-on-tekmiras-ebola-drug-while-sareptas-sits-unused/. Accessed December 19 , 2014
26.
Jarvis
LM
,
Halford
B
Unraveling Ebola . Chem Eng News , 2014 ; 92 (48 ):8 -15 . http://cen.acs.org/articles/92/i48/Unraveling-Ebola.html. Accessed December 19 , 2014
27.
Oestereich
L
,
Ludtke
A
,
Wurr
S
,
Rieger
T
,
Muñoz-Fontela
C
,
Günther
S
Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model . Antiviral Res , 2014 ; 105 :17 -21 .
28.Understanding expanded access/compassionate use . US Food and Drug Administration website. Updated October 29 , 2014 . http://www.fda.gov/forpatients/other/expandedaccess/default.htm. Accessed December 19 , 2014
29.DOD helps fight Ebola in West Africa . Operation United Assistance . US Department of Defense website. October 2014 . http://www.defense.gov/home/features/2014/1014_ebola/. Accessed December 18 , 2014
30.H.R. 83, 113th Cong. (2014 ). https://www.congress.gov/bill/113th-congress/house-bill/83/all-info. Accessed December 18 , 2014